← FDA Drug Approvals (Drugs@FDA)

TAVALISSE

NDA · New Drug Application · Sponsor: RIGEL PHARMS · Approved 2018-04-17

Drug application

FDA Application #

NDA209299

Application type

New Drug Application

Brand name

TAVALISSE

Generic name

FOSTAMATINIB

Active ingredients

FOSTAMATINIB DISODIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

RIGEL PHARMS

Manufacturer

Rigel Pharmaceuticals, Inc.

First approval

2018-04-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown